A neutral, evidence-rated side-by-side of Trenbolone Acetate and Trenbolone Enanthate. Figures are typical reference values, not recommendations.
| Trenbolone Acetate | Trenbolone Enanthate | |
|---|---|---|
| Type | Anabolic steroid | Anabolic steroid |
| Evidence level | Emerging | Emerging |
| Primary class | Androgen | Androgen |
| Half-life | ~1 day (acetate ester) | ~5-7 days (enanthate ester) |
| Typical dose | 150–300 mg/wk | 200–300 mg/wk |
| Anabolic : androgenic | 500 : 500 | 500 : 500 |
| Aromatises | No | No |
| Hepatotoxicity | Low | Low |
| HPTA suppression | Severe | Severe |
| Documented effects | 3 | 3 |
| Documented side effects | 2 | 4 |
A potent 19-nor androgen originally developed for cattle, never approved for human use. Produces dramatic recomposition alongside the heaviest side-effect burden of any compound in common use.
Full Trenbolone Acetate page →A long-ester form of trenbolone, an extremely potent 19-nor androgen that does not aromatise but is strongly progestogenic. It produces dramatic strength and recomposition effects but carries the heaviest side-effect burden of common anabolic steroids — night sweats, insomnia, aggression, cardiovascular strain and 'tren cough'. Almost all data are veterinary or anecdotal; no human trials exist.
Full Trenbolone Enanthate page →